233 related articles for article (PubMed ID: 28577272)
1. A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).
Guittet C; Manso M; Burton I; Granier LA; Marçon F
Pharm Res; 2017 Sep; 34(9):1840-1848. PubMed ID: 28577272
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin.
Marçon F; Guittet C; Manso MA; Burton I; Granier LA; Jacqmin P; Dupont H
Eur J Pharm Sci; 2018 Mar; 114():46-54. PubMed ID: 29203151
[TBL] [Abstract][Full Text] [Related]
3. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
[TBL] [Abstract][Full Text] [Related]
4. The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.
Pentikis HS; Connolly M; Trapnell CB; Forbes WP; Bettenhausen DK
Pharmacotherapy; 2007 Oct; 27(10):1361-9. PubMed ID: 17896891
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
Berg AK; Myrvik MJ; Van Ess PJ
Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
[TBL] [Abstract][Full Text] [Related]
6. Intranasal midazolam: a comparison of two delivery devices in human volunteers.
Dale O; Nilsen T; Loftsson T; Hjorth Tønnesen H; Klepstad P; Kaasa S; Holand T; Djupesland PG
J Pharm Pharmacol; 2006 Oct; 58(10):1311-8. PubMed ID: 17034653
[TBL] [Abstract][Full Text] [Related]
7. Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects.
Zhou S; Zhu J; Sun X; Xie L; Zhao Y; Ding S; Wang L; Chen J; Zhu B; Zheng A; Li Y; Zhou C; Shao F
Clin Drug Investig; 2023 Jun; 43(6):421-433. PubMed ID: 37270744
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas.
Aarnes TK; Fry PR; Hubbell JA; Bednarski RM; Lerche P; Chen W; Bei D; Liu Z; Lakritz J
Am J Vet Res; 2013 Feb; 74(2):294-9. PubMed ID: 23363357
[TBL] [Abstract][Full Text] [Related]
9. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients.
Boulieu R; Lehmann B; Salord F; Fisher C; Morlet D
Eur J Drug Metab Pharmacokinet; 1998; 23(2):255-8. PubMed ID: 9725490
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.
Haschke M; Suter K; Hofmann S; Witschi R; Fröhlich J; Imanidis G; Drewe J; Briellmann TA; Dussy FE; Krähenbühl S; Surber C
Br J Clin Pharmacol; 2010 Jun; 69(6):607-16. PubMed ID: 20565452
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of midazolam following intravenous and intramuscular administration to sheep.
Simon BT; Scallan EM; O O; Ebner LS; Cerullo MN; Follette C; Cox SK; Doherty TJ; Lizarraga I
Am J Vet Res; 2017 May; 78(5):539-549. PubMed ID: 28441044
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.
Schrier L; Zuiker R; Merkus FW; Klaassen ES; Guan Z; Tuk B; van Gerven JM; van der Geest R; Groeneveld GJ
Br J Clin Pharmacol; 2017 Apr; 83(4):721-731. PubMed ID: 27780297
[TBL] [Abstract][Full Text] [Related]
14. Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice.
Andersen V; Pedersen N; Larsen NE; Sonne J; Larsen S
Br J Clin Pharmacol; 2002 Aug; 54(2):120-4. PubMed ID: 12207630
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.
Platten HP; Schweizer E; Dilger K; Mikus G; Klotz U
Clin Pharmacol Ther; 1998 May; 63(5):552-60. PubMed ID: 9630828
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans.
Gudmundsdottir H; Sigurjonsdottir JF; Masson M; Fjalldal O; Stefansson E; Loftsson T
Pharmazie; 2001 Dec; 56(12):963-6. PubMed ID: 11802661
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
[TBL] [Abstract][Full Text] [Related]
18. Plasma pharmacokinetics of midazolam in chickens, turkeys, pheasants and bobwhite quail.
Cortright KA; Wetzlich SE; Craigmill AL
J Vet Pharmacol Ther; 2007 Oct; 30(5):429-36. PubMed ID: 17803735
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of a novel midazolam gel after intranasal administration in dogs.
Eagleson JS; Platt SR; Strong DL; Kent M; Freeman AC; Nghiem PP; Zheng B; White CA
Am J Vet Res; 2012 Apr; 73(4):539-45. PubMed ID: 22452501
[TBL] [Abstract][Full Text] [Related]
20. Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers.
Brill MJ; van Rongen A; Houwink AP; Burggraaf J; van Ramshorst B; Wiezer RJ; van Dongen EP; Knibbe CA
Clin Pharmacokinet; 2014 Oct; 53(10):931-41. PubMed ID: 25141974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
